TPSD1
Basic information
Region (hg38): 16:1256059-1259008
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TPSD1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 29 | 31 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 29 | 1 | 2 |
Variants in TPSD1
This is a list of pathogenic ClinVar variants found in the TPSD1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
16-1256294-C-T | not specified | Uncertain significance (Mar 01, 2024) | ||
16-1256309-G-A | not specified | Uncertain significance (Aug 02, 2021) | ||
16-1256332-G-A | not specified | Uncertain significance (Aug 12, 2021) | ||
16-1256537-A-G | not specified | Likely benign (Jul 14, 2021) | ||
16-1256540-C-T | not specified | Uncertain significance (Jul 14, 2021) | ||
16-1256551-G-T | not specified | Uncertain significance (Jun 01, 2023) | ||
16-1256608-G-A | not specified | Uncertain significance (Jul 26, 2022) | ||
16-1256632-G-C | not specified | Uncertain significance (Aug 15, 2023) | ||
16-1256639-C-T | not specified | Uncertain significance (Nov 27, 2023) | ||
16-1256645-T-A | not specified | Uncertain significance (Jan 04, 2022) | ||
16-1256668-G-A | not specified | Uncertain significance (Apr 20, 2024) | ||
16-1256669-C-G | not specified | Uncertain significance (Jan 23, 2024) | ||
16-1256669-C-T | not specified | Uncertain significance (Jun 24, 2022) | ||
16-1256672-C-T | not specified | Uncertain significance (May 28, 2024) | ||
16-1256677-T-A | not specified | Uncertain significance (Apr 09, 2024) | ||
16-1256824-G-C | Bladder exstrophy-epispadias-cloacal extrophy complex | Uncertain significance (-) | ||
16-1256835-G-A | not specified | Uncertain significance (Mar 18, 2024) | ||
16-1256840-C-A | not specified | Uncertain significance (Apr 13, 2023) | ||
16-1256897-C-G | not specified | Uncertain significance (Jun 24, 2022) | ||
16-1256913-A-G | not specified | Uncertain significance (Mar 07, 2023) | ||
16-1256918-G-A | not specified | Uncertain significance (Aug 13, 2021) | ||
16-1256936-C-A | not specified | Uncertain significance (May 16, 2023) | ||
16-1256960-A-G | not specified | Likely benign (Mar 20, 2024) | ||
16-1256963-T-A | not specified | Uncertain significance (Apr 04, 2023) | ||
16-1256985-C-A | not specified | Uncertain significance (Dec 02, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
TPSD1 | protein_coding | protein_coding | ENST00000211076 | 5 | 2473 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
8.04e-12 | 0.0106 | 74442 | 8009 | 43240 | 125691 | 0.230 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -1.62 | 208 | 152 | 1.37 | 0.00000971 | 1502 |
Missense in Polyphen | 69 | 54.576 | 1.2643 | 598 | ||
Synonymous | -2.47 | 98 | 71.4 | 1.37 | 0.00000529 | 466 |
Loss of Function | -0.946 | 15 | 11.5 | 1.30 | 5.97e-7 | 104 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.767 | 0.761 |
Ashkenazi Jewish | 0.337 | 0.325 |
East Asian | 0.164 | 0.164 |
Finnish | 0.158 | 0.158 |
European (Non-Finnish) | 0.203 | 0.200 |
Middle Eastern | 0.164 | 0.164 |
South Asian | 0.185 | 0.183 |
Other | 0.258 | 0.251 |
dbNSFP
Source:
- Function
- FUNCTION: Tryptase is the major neutral protease present in mast cells and is secreted upon the coupled activation-degranulation response of this cell type. {ECO:0000250}.;
Recessive Scores
- pRec
- 0.168
Intolerance Scores
- loftool
- 0.208
- rvis_EVS
- 1.71
- rvis_percentile_EVS
- 96.46
Haploinsufficiency Scores
- pHI
- 0.280
- hipred
- N
- hipred_score
- 0.112
- ghis
- 0.429
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.203
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Gene ontology
- Biological process
- proteolysis
- Cellular component
- extracellular space
- Molecular function
- serine-type endopeptidase activity;serine-type peptidase activity